Association between steatotic liver disease subtype and thyroid cancer in women: A nationwide population-based cohort study
Open Access
- 21 May 2026
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Endocrinology
- Vol. 17, 1801839
Abstract
Objective: This study aimed to investigate association between steatotic liver disease (SLD) subtype and thyroid cancer in women using a nationwide population-based cohort. Methods: This nationwide population-based cohort study included 2,089,609 women aged more than 40 years who participated in the 2009 health screening program and were followed up until 2022. Participants were divided into four groups based on their SLD status: no SLD, metabolic dysfunction-associated steatotic liver disease (MASLD), metabolic dysfunction and alcohol-related liver disease (MetALD), and alcohol-related liver disease (ALD). Results: During a mean follow-up of 12.27 years, 40,072 (1.92%) women were newly diagnosed with thyroid cancer. Compared with the no SLD group, women with MASLD had a higher risk of thyroid cancer (hazard ratio [HR]: 1.19, 95% confidence interval [CI]: 1.16-1.22), whereas those with MetALD and ALD did not have a higher risk. The risk of thyroid cancer was higher in women with MASLD, including both premenopausal (HR: 1.21, 95% CI: 1.16-1.26) and postmenopausal women (HR: 1.17, 95% CI: 1.14-1.21). Women in the MetALD group showed no risk elevation of thyroid cancer regardless of their menopausal status. Postmenopausal women in the ALD group had a higher risk of thyroid cancer than those in the no SLD group (HR: 1.31, 95% CI: 1.05-1.64), whereas premenopausal women did not have a higher risk. Conclusions: Thyroid cancer risk was modestly increased in women with MASLD, whereas no significant associations were observed for MetALD or ALD.Keywords
This publication has 43 references indexed in Scilit:
- Association between metabolic dysfunction-associated steatotic liver disease, metabolic dysfunction subtypes and risk of colorectal cancer: A prospective cohort studyClinics and Research in Hepatology and Gastroenterology, 2025
- Current status and future trends of the global burden of MASLDTrends in Endocrinology & Metabolism, 2024
- Reproductive Factors and Risk of Thyroid Cancer in Women: An Analysis in the Nurses’ Health Study IIWomen's Health Issues, 2021
- Obesity and cancer risk: Emerging biological mechanisms and perspectivesMetabolism, 2019
- Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of diseaseHepatology, 2017
- Trends in Thyroid Cancer Incidence and Mortality in the United States, 1974-2013JAMA, 2017
- Baseline and lifetime alcohol consumption and risk of differentiated thyroid carcinoma in the EPIC studyBritish Journal of Cancer, 2015
- Increased risk of papillary thyroid cancer related to hormonal factors in womenTumor Biology, 2015
- Nonalcoholic Fatty Liver Disease, Hepatic Insulin Resistance, and Type 2 DiabetesHepatology, 2013
- Alcohol intake and risk of thyroid cancer in the NIH-AARP Diet and Health StudyBritish Journal of Cancer, 2009